로딩 중…
지수 로딩 중…
제이엘케이
322510· KOSDAQ· Health Care· Health Care Equipment & Services
₩5,000-11.66%
2026-06-19
Price Chart
제이엘케이-14.53%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 128.63B KRW |
| Revenue | 3.27B KRW |
| Net Income | -14.21B KRW |
| Total Assets | 72.29B KRW |
| Net Assets | 38.42B KRW |
| Employees | 83 |
| Value | |
| P/B | 3.35x |
| P/S | 39.38x |
| Profitability | |
| ROE | -36.98% |
| ROA | -19.65% |
| Op. Margin | -404.50% |
| Revenue Growth | -15.07% |
| Financial Health | |
| Debt Ratio | 188.17% |
| Total Debt | 52.57B KRW |
| Cash | 4.94B KRW |
| Current Ratio | 1.97x |
| Performance | |
| 1Y Return | -14.53% |
| 1M Return | 6.04% |
| From 52W High | -45.71% |
| 1Y MDD | -57.61% |
| Trading | |
| Volume | 270,043 shares |
| Foreign Own. | 0.38% |
| Per Share | |
| EPS | -556 KRW |
| BPS | 1,503 KRW |
Company Info
Established in 2014 and listed on KOSDAQ in 2019, JLK is a medical artificial intelligence solution specialized enterprise. Leveraging AI technology, the company offers early disease diagnosis, interpretation support, and lesion detection services through the analysis of medical images such as MRI, CT, and X-Ray. JLK is commercializing MEDIHUB STROKE and Cancer Solution, and is pursuing global expansion with 76 worldwide permits and approvals. The company is headquartered in Cheongju-si, Chungcheongbuk-do.